Results of a Phase I Trial of Induction Cisplatin, Docetaxel, 5-FU and Erlotinib followed by Cisplatin, Bevacizumab and Erlotinib with Radiotherapy for Advanced Head and Neck Cancer

被引：0
|
作者：
Ahn, P. [1 ]
Machtay, M. [2 ]
Anne, P. R. [1 ]
Wuthrick, E. [1 ]
Keane, W. M. [1 ]
Keane, W. M. [1 ]
Cognetti, D. [1 ]
Dicker, A. P. [1 ]
Axelrod, R. S. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Case Western Reserve Univ Hosp, Cleveland, OH 44106 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.1027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S437 / S437
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Herchenhorn, D
    Dias, FL
    Araújo, CM
    Ferreira, CG
    Bezerra, M
    Hermont, P
    Lima, RA
    Porto, AL
    Pereira, CG
    Martins, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 523S - 523S
  • [32] Mature results of a phase I trial of bortezomib, cisplatin, and radiotherapy for advanced or recurrent head and neck cancer.
    Axelrod, R. S.
    Ahn, P. H.
    Kubicek, G. J.
    Anne, P. R.
    Cognetti, D.
    Dicker, A.
    Machtay, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Herchenhorn, D.
    Dias, F. L.
    Ferreira, C. G.
    Bezerra, M.
    Fonseca, A. J.
    Mora, P.
    Pineda, R. M.
    Fontao, K.
    Knust, R. E.
    Martins, R. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 298S - 298S
  • [34] Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer
    Cascone, Tina
    Gold, Kathryn A.
    Swisher, Stephen G.
    Liu, Diane D.
    Fossella, Frank V.
    Sepesi, Boris
    Pataer, Apar
    Weissferdt, Annikka
    Kalhor, Neda
    Vaporciyan, Ara A.
    Hofstetter, Wayne L.
    Wistuba, Ignacio I.
    Heymach, John V.
    Kim, Edward S.
    William, William N., Jr.
    ANNALS OF THORACIC SURGERY, 2018, 105 (02): : 418 - 424
  • [35] PHASE I/II STUDY OF ERLOTINIB COMBINED WITH CISPLATIN AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Herchenhorn, Daniel
    Dias, Fernando L.
    Viegas, Celia M. P.
    Federico, Miriam H.
    Araujo, Carlos Manoel M.
    Small, Isabelle
    Bezerra, Marcos
    Fontao, Karina
    Knust, Renata E.
    Ferreira, Carlos G.
    Martins, Renato G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 696 - 702
  • [36] Induction and concomitant chemoradiotherapy (CCRT) using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with stage IVB advanced head and neck cancer
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawa, Shin-ichi
    Tuchida, Kodai
    Kusaka, Takahiro
    Ohashi, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with docetaxel, cisplatin and 5-FU (DCF) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Even, C.
    Texier, M.
    Le Tourneau, C.
    Bahleda, R.
    Borcoman, E.
    Vinches, M.
    Toussaint, P.
    Marabelle, A.
    Breuskin, I.
    Cupissol, D.
    Fayette, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S682 - S683
  • [38] Phase I Trial of Bevacizumab followed by Concurrent Radiation, Bevacizumab and Cisplatin for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
    Harari, P. M.
    Khuntia, D.
    Traynor, A. M.
    Hoang, T.
    Hartig, G. K.
    McCulloch, T. M.
    Jeraj, R.
    Nyflot, M.
    Wiederholt, P. A.
    Gentry, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S104 - S104
  • [39] Study of induction docetaxel, cisplatin, cetuximab and bevacizumab (TPE-A) followed by concurrent radiotherapy, cisplatin, cetuximab and bevacizumab (XPE-A) in patients with high-risk locally advanced head and neck cancer
    Akinyi-Joseph, Grace M.
    Wehbe, Ahmad Mouhamad
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer
    Rischin, D
    Peters, L
    Hicks, R
    Hughes, P
    Fisher, R
    Hart, R
    Sexton, M
    D'Costa, I
    von Roemeling, R
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 535 - 542
12345